PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
334 hedge funds and large institutions have $6B invested in PRA Health Sciences, Inc. in 2018 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 126 increasing their positions, 128 reducing their positions, and 49 closing their positions.
2% less repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 128
8% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 49
2% less funds holding
Funds holding: 342 → 334 (-8)
14% less capital invested
Capital invested by funds: $7.01B → $6B (-$1.02B)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
53% less call options, than puts
Call options by funds: $3.59M | Put options by funds: $7.67M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PG
Pendal Group
Sydney,
Australia
|
+$89.4M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$68.3M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$54.1M |
| 4 |
Millennium Management
New York
|
+$50.7M |
| 5 |
NIPH
NN Investment Partners Holdings
The Hague,
Netherlands
|
+$48.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
-$48.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$47.9M |
| 3 |
Bank of New York Mellon
New York
|
-$28.1M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$28M |
| 5 |
Morgan Stanley
New York
|
-$21.9M |
PRAH Hedge Fund Activity: Q4 2018 in Review
334 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q4 2018, worth a combined $6B — down 14% from $7.01B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of PRAH and 45 opened new positions — a net loss of 4 holders — while 128 trimmed existing stakes and 126 added.
The largest buyer was Pendal Group, opening a new position worth an estimated $89.4M. The largest seller was Laurion Capital Management, cutting an estimated $48.1M.
- 334 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q4 2018, down from 342 in Q3 2018.
- Funds reported $6B of PRA Health Sciences, Inc. stock for Q4 2018, down 14% quarter-over-quarter.
- 45 funds opened new PRA Health Sciences, Inc. positions in Q4 2018 and 49 closed out, a net change of -4 holders.
- The largest PRA Health Sciences, Inc. buyer in Q4 2018 was Pendal Group, an estimated $89.4M added.
- The largest PRA Health Sciences, Inc. seller in Q4 2018 was Laurion Capital Management, an estimated $48.1M sold.
Based on aggregated 13F filings for Q4 2018.